BOSTON – March 12, 2024 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced their first-time sponsorship of the 7th Annual Gene Therapy for Rare Disorders conference to be held March 26-29, 2024, in Boston, Massachusetts…. Read more »
PHILADELPHIA – March 11, 2024 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced their sponsorship of the 2024 ACCESS USA Conference to be held March 19-21, 2024, in Philadelphia, PA. Paysign has been a long-time… Read more »
Our guest post, “Copay Comes Full Circle – An Industry Ready for Disruption” is featured on Drug Channels, an established site which includes expert insights on pharmaceutical economics and the drug distribution system. This article discusses how copay programs have become commoditized – and identifies how many other patient affordability providers have poured resources into… Read more »
Paysign is eager to be an exhibition partner at the 7th Annual Gene Therapy for Rare Disorders Summit in Boston, MA on March 26-29, 2024. This annual event returns as the industry’s leading meeting for success stories, as well as tackling key challenges that face clinical therapies today. Our Patient Affordability team will be there… Read more »
Henderson, Nev. – February 27, 2024 – (Business Wire) – Paysign Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing, will discuss fourth quarter and full-year 2023 earnings at 5:00 p.m. EDT on Tuesday, March 26, 2024. Participant details are as follows: U.S…. Read more »
Paysign is excited to be a supporting sponsor at the ACCESS USA event, “Accelerating Access, Partnerships and Collaboration to Deliver Superior Patient Outcomes”, in Philadelphia, PA on March 19-21, 2024. Our Patient Affordability team will be there, sharing insights on patient access, pricing, copay accumulators, and the continued need for transparency within and throughout the… Read more »
Paysign to Sponsor the Trade and Channel Strategies 2023 Conference Paysign is excited to be a supporting sponsor at the upcoming Trade & Channel Strategies: Master the Complexities of Pharmacy and Distribution Models to Accelerate Market Access conference in Philadelphia, PA, December 11-13, 2023. Our team of patient affordability experts will be attending, sharing insights… Read more »
Paysign is a sponsor at the 2023 PPTA Plasma Protein Forum. Paysign is proud to be a sponsor of the two-day PPTA Plasma Protein Forum in Washington, D.C., on November 14-15, 2023! This annual event brings together industry leaders, policymakers, healthcare providers, and patients to learn and discuss key developments and issues within the plasma… Read more »
HENDERSON, Nev. – November 7, 2023 – (ACCESSWIRE) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing, today announced financial results for the third quarter 2023. “In the third quarter, we delivered strong top and bottom-line growth, with a 17% increase… Read more »
Paysign is excited to be a supporting sponsor at the upcoming Copay, Reimbursement, and Access Congress event in Philadelphia, PA on October 2-4, 2023. On October 3, Matt Turner, President of Patient Affordability, will be speaking at a general session, Winning the Race for Patient Access: Copay Accumulator Strategies and Mitigation, at 3:00 p.m. Our… Read more »
Want to learn more? Let’s talk about how Paysign can help you achieve your goals.